Gillies, Michael A.
Sander, Michael
Shaw, Andrew
Wijeysundera, Duminda N.
Myburgh, John
Aldecoa, Cesar
Jammer, Ib
Lobo, Suzana M.
Pritchard, Naomi
Grocott, Michael P. W.
Schultz, Marcus J.
Pearse, Rupert M.
Article History
Received: 10 January 2017
Accepted: 17 May 2017
First Online: 8 June 2017
Compliance with ethical standards
:
: RMP holds research grants, and has given lectures and/or performed consultancy work for Nestle Health Sciences, BBraun, Medtronic, Glaxo Smithkline and Edwards Lifesciences, and is a member of the associate editorial board of the<i> British Journal of Anaesthesia</i>.JM was the principal investigator of the CHEST trial; his institution, the George Institute for Global Health, has received unrestricted grant funding from Fresenius Kabi and Baxter Healthcare in relation to fluid resuscitation research; he is supported by a Practitioner Fellowship from the National Health and Medical Research Council of Australia.MPWG serves on the medical advisory board of Sphere Medical Ltd and has given lectures for Edwards Lifesciences, Fresenius Kabi and BOC Medical (Linde Group), Ely-Lilly Critical Care, Cortex GmBH. MPWG is the UK NIHR CRN National Specialty Lead for Anaesthesia, Perioperative Medicine and Pain. MPWG is also executive chair of the Xtreme Everest (XE) Oxygen Research Consortium and leads the Fit-4-Surgery research collaboration. MPWG is an associate editor of the journal <i>Perioperative Medicine</i> and editor-in-chief of the journal <i>Extreme Physiology and Medicine</i>. AS is a consultant for Baxter, Astute, Edwards and FAST medical. All other authors declare they have no conflicts of interest.
Free to read: This content has been made available to all.